GLP-1 Drugs for Seniors: Promise or Risk | Science News

Medicare’s new GLP-1 Bridge program caps three weight-loss drugs at $50 a month, making them accessible to millions of seniors battling obesity—but experts warn it’s not a one-size-fits-all solution. While these drugs mimic hormones that curb appetite, they carry risks for older adults: constipation, dehydration, muscle loss, and falls. The real goal for seniors shouldn’t be just weight loss, but improved mobility and function. Long-term safety and effectiveness, especially for frail elders, remain uncertain, and lifestyle changes still stand as the gold standard. Listen in comfort:Get a discount on a Soli Pillow: http://solipillow.com/discount/dnn. Advertise on DNN:[email protected] This is an automated, high-level news summary based on public reporting.Report issues to [email protected]. View sources & latest updates:https://sources.thednn.ai/4c319b7f92183ae3